Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Acute stroke during the COVID-19 pandemic. Experience from the National Institute of Neurology and Neurosurgery, Mexico.
Cerebrovascular Disease and Interventional Neurology
Cerebrovascular Disease and Interventional Neurology Posters (7:00 AM-5:00 PM)
015
To describe treatment of Stroke (either hemorrhagic or ischemic) and its quality metrics  before and during the pandemic of COVID 19. 

During the COVID pandemic the Mexican health systems suffered major changes. Many hospitals dedicated their entire services to treatment of COVID-19 and its complications. That made referral institutions such as ours the only centers available to treat patients with acute stroke.

Using the data from the Registry of Stroke Care Quality (RESQ) for the National Institute of Neurology and Neurosurgery “Manuel Velasco Suárez”, we describe the frequency of Acute Stroke and the quality of stroke care, from January 1st 2019 until February 28th 2020 and compared it with data from March 1st 2020 until June 30th 2020 (the beginning of the COVID 19 pandemic in Mexico). 

 From January 1st until the 30th June 2020, 202 patients with the diagnosis of stroke were admitted to our institution. Length of stay was different (14  vs 8.5 days). The type of stroke was also different, before the pandemic 35% were ischemic, 14.2% were intracerebral hemorrhage, 48.2% were subarachnoid hemorrhage. During the pandemic the proportion of Ischemic stroke (46.3%) and intracerebral hemorrhages (18.3%) were higher. More patients underwent advanced carotid imaging. (25% vs 41.5%). More patients received thrombolytic therapy (16.7% vs 28.9%) and door-to-needle time was reduced from 70.vs 41. minutes. Time from onset of symptoms increased from 644 to 839 minutes. 

The COVID 19 pandemic brought changes in the presentation an in the way we treat stroke in our center. These changes range from the difficulty for the patients to arrive to our hospital from other centers to a improvement of time to treatment. Both an increase in the number of patients due to the collapse of the local health system and the preservation of the quality of stroke care was observed.

Authors/Disclosures
Raul Medina-Rioja, MD
PRESENTER
Dr. Medina-Rioja has nothing to disclose.
Sergio Saldivar, MD (Insituto Nacional de Neurologia y Neurocirugia "Dr. Manuel Velasco Suraez") Dr. Saldivar has nothing to disclose.
Juan Calleja, MD (ABC Medical Center) Dr. Calleja has nothing to disclose.